Invest-NL

– Onera closed the Series B funding round, which brought the total funding raised to date above the €24M mark.
– Innovation Industries led the round in collaboration with Invest-NL and with existing investors Jazz Pharmaceuticals, imec.xpand, BOM and 15th Rock.
– The company intends to use the funds to execute clinical studies and further commercialize its sleep diagnostics and monitoring products in Europe and the United States.
– Onera recently relocated its headquarters to the Brainport region in Eindhoven, the Netherlands, while maintaining commercial operations in the United States.

– ISA Pharmaceuticals B.V. from Oegstgeest, The Netherlands closed a €26m funding round.
– Backers included new investor – Invest-NL and existing investors including Regeneron.
– The company intends to use the funds to advance the lead product ISA101b towards first marketing authorization as well as to broaden the clinical pipeline of immunotherapies based on the Synthetic Long Peptide (SLP®) platform technology.